Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study
Abstract Background Endocrine drugs may affect lipid metabolism in breast cancer (BC) patients. This study explores lipid changes in early-stage BC patients taking different endocrine drugs. Methods The changing trend of blood lipid during endocrine therapy in 2756 BC patients from January 2013 to D...
Main Authors: | Yuechong Li, Zixi Deng, Yingjiao Wang, Songjie Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12944-024-02002-6 |
Similar Items
-
Patient‐reported outcome and survival in premenopausal hormone receptor‐positive breast cancer patients at moderate to high risk: comparing toremifene with aromatase inhibitor in a real‐world study
by: Yaping Yang, et al.
Published: (2024-10-01) -
A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study
by: Gu Ran, et al.
Published: (2012-05-01) -
The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy
by: Jing Xu, et al.
Published: (2023-07-01) -
Risk of developing depression from endocrine treatment: A nationwide cohort study of women administered treatment for breast cancer in South Korea
by: Jooyoung Oh, et al.
Published: (2022-09-01) -
Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer
by: Li Huifang, et al.
Published: (2022-12-01)